Green silver nanoparticles of Phyllanthus amarus: as an antibacterial agent against multi drug resistant clinical isolates of Pseudomonas aeruginosa by Khushboo Singh et al.
Singh et al. Journal of Nanobiotechnology 2014, 12:40
http://www.jnanobiotechnology.com/content/12/1/40RESEARCH Open AccessGreen silver nanoparticles of Phyllanthus amarus:
as an antibacterial agent against multi drug
resistant clinical isolates of Pseudomonas
aeruginosa
Khushboo Singh1, Manju Panghal1, Sangeeta Kadyan1, Uma Chaudhary2 and Jaya Parkash Yadav1*Abstract
Background: Pseudomonas aeruginosa infection is a leading cause of morbidity and mortality in burn and
immune-compromised patients. In recent studies, researchers have drawn their attention towards ecofriendly
synthesis of nanoparticles and their activity against multidrug resistant microbes. In this study, silver nanoparticles
were synthesized from aqueous extract of Phyllanthus amarus. The synthesized nanoparticles were explored as a
potent source of nanomedicine against MDR burn isolates of P. aeruginosa.
Results: Silver nanoparticles were successfully synthesized using P. amarus extract and the nature of synthesized
nanoparticles was analyzed by UV-Vis spectroscopy, transmission electron microscopy, energy dispersive X-ray
spectroscopy, dynamic light scattering, zeta potential, X- ray diffraction and fourier transform infra-red spectroscopy.
The average size of synthesized nanoparticles was 15.7, 24 ± 8 and 29.78 nm by XRD, TEM and DLS respectively. The
antibacterial activity of AgNPs was investigated against fifteen MDR strains of P. aeruginosa tested at different
concentration. The zone of inhibition was measured in the range of 10 ± 0.53 to 21 ± 0.11mm with silver nanoparticles
concentration of 12.5 to 100 μg/ml. The zone of inhibition increased with increase in the concentration of silver
nanoparticles. The MIC values of synthesized silver nanoparticles were found in the range of 6.25 to12.5 μg/ml.
The MIC values are comparable to the standard antibiotics.
Conclusion: The present study suggests that silver nanoparticles from P. amarus extract exhibited excellent
antibacterial potential against multidrug resistant strains of P. aeruginosa from burn patients and gives insight of
their potential applicability as an alternative antibacterial in the health care system to reduce the burden of
multidrug resistance.
Keywords: Pseudomonas aeruginosa, Burn isolates, MDR, Phyllanthus amarus, Silver nanoparticles, AntibacterialBackground
Pseudomonas aeruginosa, a gram negative bacterium, is
the leading cause of morbidity and mortality in burn pa-
tients as they are more susceptible to infections because
of immune-suppression and loss of cutaneous coverage
[1]. Since P. aeruginosa has innate potential to develop
resistance, virtually to any antibiotics to which it is ex-
posed, due to the presence of multiple resistance mecha-
nisms and it becomes a multidrug resistant (MDR) strain.* Correspondence: yadav1964@rediffmail.com
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unless otherwise stated.Infections caused by MDR P. aeruginosa are often severe;
life threatening and these strains have frequently been re-
ported as the cause of nosocomial infections. These MDR
have been emerged as a major problem in burn units as
burn injury disrupts both the normal skin barrier and
many of systemic host defence mechanism which make
burn patients the ideal hosts for opportunistic infections
[2]. The importance to prevent these infections has been
recognized since its inception thus it becomes difficult to
treat the infection caused by P. aeruginosa MDR strains
due to their narrow range of susceptibility to antimicrobial
agents. Therefore, currently, researchers started to developtd. This is an Open Access article distributed under the terms of the Creative
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Figure 1 Image of TEM of silver nanoparticles of P. amarus.
Figure showing picture of transmission electron microscopy of silver
nanoparticles of P. amarus.
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fections. In future, these alternatives may be useful in
treating not only burn infections but other antibiotic re-
sistant infections as well.
Nanotechnology provides a good platform to modify
and develop the important properties of silver metal in
the form of nanoparticles having promising applications
as an antibacterial agent [3,4]. Silver nanoparticles have
high surface area to volume ratio and the unique chem-
ical, physical properties [5,6]. Nowadays, they have been
widely used as an effective bactericidal agent against
broad spectrum of bacteria, including antibiotic resistant
strains [7]. Hence, researchers are shifting towards nano-
particles in general and silver nanoparticles (AgNPs) in
particular to solve the problem of emergence of MDR
bacteria [8]. Also the development of biological ap-
proach for the synthesis of nanoparticles is evolving in
to an important branch of nanotechnology [9,10]. The
biological method has advancement over chemical and
physical method as it is cost effective and ecofriendly
[11,12]. Phyllanthus amarus is an important plant of In-
dian Ayurvedic system of medicine, belongs to the fam-
ily Euphorbiaceae. It is a small herb well known for its
medicinal properties and has been used worldwide [13].
This study aims to explore the efficacy of synthesized
silver nanoparticles from P. amarus as a potent source of
nanomedicine against MDR burn isolates of P. aeruginosa
and establish the therapeutic antibacterial potential of
plant with nanotechnology; thereby justify the folklore




The AgNPs were successfully synthesized using aqueous
plant extract of P. amarus by mixing with silver nitrate
solution (1mM). The colour changes from pale yellow to
dark brown (Additional file 1: Figure S1). This was ob-
served due to the reduction of Ag+ and it indicates the
formation of AgNPs.
Characterization of Ag nanoparticles
The synthesis of AgNPs was confirmed by UV-VIS
spectrophotometer (Shimadzu). The UV-VIS absorp-
tion spectra of the AgNPs were monitored in a range
of 300-800 nm. A strong peak specific for the synthesis
of silver nanoparticles was obtained at 420-430 nm.
Additional file 2: Figure S2 shows the absorption spec-
tra of AgNPs synthesized by P. amarus. The TEM re-
sults (Figure 1) showed that all synthesized AgNPs
were spherical in shape with 24 ± 8 nm size and found to
be well dispersed in aqueous medium. EDX characterization
has shown absorption of strong silver signal along with
other elements, which may be originated from thebiomolecules that are bound to the surface of silver nano-
particles. EDX performed by energy and intensity distribu-
tions of X-ray signals generated by focused electron beam
on a specimen. From EDX spectra, showed in Figure 2, it
is clear that silver nanoparticles reduced by P. amarus.
Dynamic light scattering (DLS) technique and zeta po-
tential has been used to determine the size of particles
and measure the potential stability of the particles in the
colloidal suspension respectively. Figure 3 and Figure 4
have shown the DLS and zeta potential graph of AgNPs
of P. amarus with an average size of 29.78 nm and the
particles carry a charge of -11.9 mV respectively. Silver
nanoparticles generally carry a negative charge. All silver
nanoparticles synthesized from P. amarus showed nega-
tive charge and were stable at room temperature. The
particle size and nature of AgNPs was determined by
XRD. The mean particle diameter of AgNPs was calcu-
lated using the Debye-Scherrer’s equation. An average
size of the silver nanoparticles synthesized by P. amarus
was 15.7 nm (Figure 5 and Table 1). The FT-IR spectrum
of AgNPs from P. amarus showed the characteristics
absorbance bands (Figure 6) due to aldehydic C–H
stretch (2,915 and 2,848 cm-1), C-O stretch (1,634 cm-1),
N-H (1517 cm-1), 1462 cm-1 N-O stretch (1,377 cm-1) and
C-O stretch (dialkyl) (1,169 cm-1), C-N (1,037 cm-1), C-H
stretch (718 cm-1).
Antibacterial assay
The 15 multidrug resistant strains of P. aeruginosa iso-
lated from burn patients tested at various concentrations
Figure 2 Image of EDX of silver nanoparticles of P. amarus. Figure showing picture of energy dispersive x-ray spectroscopy of silver nanoparticles
of P. amarus.
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the antibacterial effect by agar well diffusion method.
The AgNPs showed (Additional file 3: Figure S3) anti-
microbial activity against all the tested pathogens. The
antibacterial activity is concentration dependent as it in-
creased with the concentration of AgNPs (Figure 7). The
zone of inhibition measured in a range of 10 ± 0.53 to
21 ± 0.11 mm. MDR Strain1 was found (Figure 8) to be
most susceptible where zone of inhibition ranged from
13 ± 1 to 21 ± 0.11 mm at AgNPs concentration of 12.5
to 100 μg/ml. MDR strain 10 was least susceptible with
10 ± 0.53 to 13 ± 0.41mm zone of inhibition.Figure 3 DLS graph of silver nanoparticles of P. amarus. Figure showingMinimum Inhibitory Concentration (MIC)
The MIC of AgNPs from P. amarus against MDR strains
of P. aeruginosa was 6.25-12.5 μg/ml. MDR strains 6,
10,12,13,14 and 15 showed the MIC values of 12.5 μg/ml.
The remaining nine MDR strains have shown the MIC at
6.25 μg/ml (Table 2) which is lower than standard antibiotic.
Discussion
The biosynthesis of nanoparticles has received consider-
able attention due to the growing need to develop envir-
onmentally benign technologies in material synthesis
[14]. The phytochemicals derived from plant productsgraph of dynamic light scattering of silver nanoparticles of P. amarus.
Figure 4 Zeta potential graph of silver nanoparticles of P. amarus. Figure showing graph of zeta potential of silver nanoparticles of P. amarus.
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fective medicines for controlling the growth of microorgan-
isms [15]. These compounds have significant therapeutic
application against human pathogens. Numerous studies
have been conducted with the extracts of various plants for
screening of antimicrobial activity in search of new anti-
microbial compounds [16]. P. amarus was also reported to
have antibacterial efficacy against some drug resistant patho-
genic bacterial strains [17]. But there are still limited studies
regarding antibacterial activity of AgNPs from this plant.
The beauty of the present study is that AgNPs reduced
by P. amarus were highly effective against MDR burn
isolates of P. aeruginosa in term of novelty. We synthe-
sized AgNPs from P. amarus, which is easily availableFigure 5 XRD of silver nanoparticles of P. amarus. Figure showing X-Rain rainy season, safe, non-toxic and have a variety of
secondary metabolites that can help in the reduction
of silver ions. The main mechanism considered for the
process is plant-assisted reduction due to phytochemi-
cals. The main phytochemicals involved are terpenoids,
flavones, ketones, aldehydes, amides, and carboxylic
acids. Flavones, organic acids, and quinones are water-
soluble phytochemicals that are responsible for the im-
mediate reduction of the ions [18]. Studies have revealed
that P. amarus contain mainly phyllanthin, hypophyl-
lanthin, phyltertralin and many more other phytochemi-
cals [19]. It was also suggested that the phytochemicals
are involved directly in the reduction of the ions and for-
mation of silver nanoparticles [20]. Though the exacty Diffraction pattern of silver nanoparticles of P. amarus.
Table 1 Size of AgNPs of P. amarus by using Debye-Scherrer’s equation
S. No. 2-theta(deg) D (ang.) FWHM(deg) Int. I(cps deg) Int. W(deg) Size(nm)
1 27.797 3.206 0.464 488.7 0.651 18.4
2 32.210 2.776 0.450 1008.65 0.622 19.1
3 38.094 2.306 0.647 845.25 0.992 13.5
4 44.195 2.047 1.204 224.79 1.535 7.43
5 46.250 1.961 0.576 492.67 0.702 15.6
6 54.750 1.675 0.532 152.66 0.722 17.5
7 57.450 1.602 0.610 148.96 0.825 15.4
8 64.485 1.443 0.367 171.27 0.758 26.6
9 77.068 1.236 1.285 258.17 1.368 8.25
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presence of different phytochemicals which are involved
in the reduction of the ions leads to the synthesis of
AgNPs. A strong peak was obtained at 420-430 nm
showing the absorption spectra of AgNPs synthesized
by P. amarus. Further EDX has shown absorption of
strong silver signal along with other elements that are
bound to the surface of silver nanoparticles. TEM,
XRD, DLS revealed the size and zeta potential contrib-
uted towards the stability of AgNPs [21]. FTIR confirms
the presence of different functional groups absorb charac-
teristic frequencies of IR radiations [22].
The exact mechanism by which silver nanoparticles em-
ploy to cause antimicrobial effect is not clearly known.Figure 6 FTIR of silver nanoparticles of P. amarus. Figure showing FourieHowever, there are various theories suggested about the
action of AgNPs on microbes to cause the antimicrobial
effect. The AgNPs have ability to anchor to the bacterial
cell wall and subsequently penetrate it, thereby causing
structural changes in the cell membrane like the perme-
ability of cell membrane and death of the cell. There is
formation of ‘pits’ on the cell surface where accumulation
of the nanoparticles takes place [23]. The formation of free
radicals by AgNPs may be considered to be another mech-
anism by which the cells die [24,25]. It has also been pro-
posed that there can be release of silver ions by the
nanoparticles [26], and these ions can interact with the
thiol groups of many vital enzymes and inactivate them
[27]. The bacterial cells in contact with silver absorb silverr Transform Infra-Red spectroscopy of silver nanoparticles of P. amarus.
Figure 7 Graph showing antibacterial activity of silver
nanoparticles of P. amarus. Figure showing graph of antibacterial
activity of silver nanoparticles of P. amarus at different concentration
against 15 MDR strains of P. aeruginosa from burn patients.
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age the cells.
In recent years, due to the development of resistant
strains, antibiotic resistance also has been increased.
MDR P. aeruginosa strains from burn patients are caus-
ing serious infections and exhibit innate resistance to
many antibiotics. These can develop new resistance after
exposures to antimicrobial agents. Some antimicrobial
agents are extremely irritant and toxic. The studies on
drug resistant bacteria in this facet are still limited. Also
AgNPs have gained insight as an excellent antimicrobial
agent due to its non-toxic effect on human cells in its
low concentration and weaker ability to develop resist-
ance towards silver ions [28-30].
The various researchers showed that AgNPs of P. amarus
were found to be good antibacterial agent. Humberto et al.
[31] showed the antibacterial activity of AgNPs against
multidrug-resistant P. aeruginosa, E. coli, Streptococcus sp.Figure 8 Graph showing antibacterial activity of silver nanoparticles of
of antibacterial activity of silver nanoparticles of P. amarus at different concenand S. pyogens. Kathireshwari et al. [32] showed the anti-
microbial activity against multi drug resistant human
pathogens from leaf mediated synthesis of AgNPs using
Phyllanthus niruri. Durairaj et al. [33] studied the antibac-
terial activity of purchased AgNPs (size 20-30 nm) against
10 isolates of P. aeruginosa comprising of 5 MDR strains
with an inhibition zone of 11 mm observed with10 μg
dose of the nanoparticles. In our results, AgNPs showed
excellent antibacterial activity which is better than our
previous study [34], which showed the good antibacterial
activity of AgNPs prepared using T. cordifolia aqueous ex-
tract against P. aeruginosa MDR strain from burn patient
with maximum concentration of 200 μg/ml. However,
there is vital need and much interest in finding ways to
formulate new types of safe and cost-effective biocidal ma-
terials [22]. Therefore, in this study, we used different
plant as biomaterial and evaluated its antibacterial effects.
The synthesized AgNPs showed significant antibacterial
activity at concentration of 12.5-100 μg/ml against MDR
strains of P. aeruginosa isolates. The MIC of AgNPs was
found to be in a range from 6.25-12.5 μg/ml, almost nine
MDR strains have shown the MIC at 6.25 μg/ml which
was lower than that of the standard antibiotic (10 μg). As
infection of P. aeruginosa always remains one of the most
challenging concerns in burn units and the synthesized
AgNPs of P. amarus are highly effective antibacterial
agent against these MDR burn isolates.
Conclusion
In conclusion, we have demonstrated that AgNPs from
P. amarus exhibit excellent antibacterial potential against
MDR P. aeruginosa strains isolated from burn patients.
Therefore these AgNPs may act as ecofriendly antibacter-
ial agent against these nosocomial strains and canP. amarus against representative MDR strain. Figure showing graph
tration against MDR strain 1 of P. aeruginosa from burn patients.
Table 2 MIC of silver nanoparticles of P. amarus against
MDR strains of P. aeruginosa from burn patients
S.No MIC(in μg/ml)
P. aeruginosa MDR Strain 1 6.25
P. aeruginosa MDR Strain 2 6.25
P. aeruginosa MDR Strain 3 6.25
P. aeruginosa MDR Strain 4 6.25
P. aeruginosa MDR Strain 5 6.25
P. aeruginosa MDR Strain 6 12.5
P. aeruginosa MDR Strain 7 6.25
P. aeruginosa MDR Strain 8 6.25
P. aeruginosa MDR Strain 9 6.25
P. aeruginosa MDR Strain 10 12.5
P. aeruginosa MDR Strain 11 6.25
P. aeruginosa MDR Strain 12 12.5
P. aeruginosa MDR Strain 13 12.5
P. aeruginosa MDR Strain 14 12.5
P. aeruginosa MDR Strain 15 12.5
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health care system to reduce the burden of multidrug
resistance.
Material and methods
Synthesis of silver nanoparticles from plant extract
Preparation of the extract
The whole plant of Phyllanthus amarus was collected
locally from Botanical Garden, M.D. University, Rohtak,
Haryana, India. It was thoroughly washed in distilled
water, cut into fine pieces. 10g of fresh plant material
was boiled into 100 ml sterile distilled water for 10 mi-
nutes and filtered through Whatman’s No.1 filter paper.
The extract was stored at 4°C for further experiments.
Synthesis of AgNPs from plant extract
For synthesis of AgNPs, the above plant extract of P. amarus
was used and 15 ml of this extract was added to 200 ml of
aqueous silver nitrate solution (1mM). This solution was
kept for 20 minutes at 70°C (in water bath). The plant ex-
tract act as reducing as well as stabilizing agent in the so-
lution and leads to the formation of AgNPs.
Characterization of synthesized AgNPs
The seven different characterization techniques were
used for AgNPs. At first, AgNPs were characterized by
UV-VIS Spectroscopy using Shimadzu UV-VIS Spectro-
photometer. The scanning range for the samples was
300-800 nm. The double distilled water used as a blank
reference. To remove any free biomass residue or com-
pound that is not the capping ligand of the nanoparti-
cles, after complete reduction, silver nanoparticles wereconcentrated by repeated centrifugation (3 times) of the
reaction mixture at 15,000rpm for 20 min. The super-
natant was replaced by distilled water each time. There-
after, the purified suspension was freeze dried to obtain
dried powder. The shape and size of AgNPs was deter-
mined by transmission electron microscopy (TEM). A
drop (2 ul) of water dissolved synthesized nanoparticles
was placed on a copper grid. The images were obtained
with a Tecnai, Twin 200 KV (FEI, Netherlands) at a bias
voltage of 200 kV used to analyze samples. The compos-
ition of the AgNPs was determined using the Energy
Dispersive X-Ray Spectroscopy (EDX) coupled to the
TEM. The size distribution or average size of the synthe-
sized AgNPs were determined by dynamic light scatter-
ing (DLS) and zeta potential measurements were carried
out using DLS (Malvern). For DLS analysis the samples
were diluted 10 folds using 0.15M PBS (pH 7.4) and the
measurements were taken in the range between 0.1 and
10,000 nm. X- Ray Diffraction (XRD) was done with the
help of by X-Pert Pro Diffractometer. The X-ray diffrac-
tion data were obtained using step scan technique and
with Cu-Ka radiation (1.500 Å, 40 kV, 30 mA) in h–2h
configuration. The AgNPs were coated on to the glass
substrate and after drying, the sample was analyzed by
X-ray diffractometer. The crystallite domain size was
calculated using the Debye–Scherrer’s formula. Finally,
Fourier Transform Infra-red Spectroscopy (FTIR) was
used for detection of different functional groups. The
dried AgNPs were analyzed by ALPHA FT-IR Spectrom-
eter (from Bruker, Germany) for the detection of differ-
ent functional groups by showing peaks from the region
of 4000 cm-1 to 500 cm-1.
Multi drug resistant clinical isolates of P. aeruginosa from
burn patients
Fifteen clinical isolates were obtained from the various
samples of burn patients receiving in Microbiology De-
partment of Pt. B.D.S. Post Graduate Institute of Med-
ical Sciences, Rohtak, Haryana, India. The purity and
identity of each isolate was confirmed in laboratory by
standard microbiological methods [35-37]. The sources
of the clinical isolates were urine, wounds, blood, and
body fluids of burn patients. The approval of SRAC (Sci-
entific & Research Advisory Committee) of the institute
was taken for the study with reference no. UHS/OSD/
2010/1 dated 27/02/2012. The 10 most cost-effective an-
tibiotics routinely used to treat P. aeruginosa infections
were employed in the susceptibility test. The antibiotics
included were amikacin, aztreonam, ceftizoxime, cefe-
pime, gentamicin, imipenem, netilmicin, ofloxacin, pipera-
cillin and tazobactum. For isolation of MDR strains, these
antibiotics were used and susceptibility was checked by
Kirby-Bauer disc method [38]. The strain which were re-
sistant to 6 or 7 antibiotics was taken as MDR strain.
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4 Test samples of the AgNPs were prepared in DMSO
(Dimethyl Sulfoxide). The concentrations of AgNPs were
ranges from 12.5-100 μg/ml i.e. 12.5, 25, 50 and 100 μg/ml.
The antimicrobial activities were determined by agar well
diffusion assay [39]. Under aseptic conditions, in to the Bio
safety chamber, 20 ml of MHA medium was dispensed in
to pre-sterilized petridishes. Once the media solidifies it
was then inoculated with micro-organism suspended in
peptone water. The media was then punched with 6mm
diameter hole and filled with different dilutions (varying
from 12.5 to 100 μg/ml) of AgNPs extract from stock of
20 mg/ml. Streptomycin (10 μg/ml) was used as positive
control and DMSO was used as a negative control. Finally,
the petridishes were incubated for 24 hours at 37°C. The
diameter of zone of inhibition was measured as indicated
by clear area devoid of growth of microbes. Each experi-
ment was done in triplicate.
Minimum inhibitory concentration method (MIC) was
calculated by micro broth dilution method in 96 multi-well
microtitre plates with slight modifications [40]. Qualitative
experimentation was done by resazurin indicator solution
prepared by dissolving a 270 mg tablet in 40 ml of sterile
distilled water. Purple colour of indicator (resazurin) re-
duced in the presence of living bacteria. Colour change
from purple to pink or to colourless. In the absence of liv-
ing bacteria the colour of the indicator were remain purple.
The lowest conc. at which colour change occurred was
taken as MIC.Consent
Written informed consent was obtained from the patient
for the publication of this report.Additional files
Additional file 1: Figure S1. Formation of silver nanoparticles of P. amarus.
Figure showing colour change from pale yellow to dark brown.
Additional file 2: Figure S2. Uv-Vis Spectra of silver nanoparticles of P.
amarus. Figure showing Uv-Vis absorption spectra of silver nanoparticles
at range of 300-800.
Additional file 3: Figure S3. Picture of antibacterial activity of AgNPs
against 15 MDR strains of P aeruginosa. Figure showing antibacterial
activity of AgNPs against 15 MDR strains of P aeruginosa at concentration
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